Recall: D-0483-2015

Class II - Potentially Harmful

Class IIClassification

2015-01-23Initiated

TerminatedStatus

Hospira Inc.Firm

Product

KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49

Reason

Crystallization

Distribution

U.S. Nationwide and International: Guam and Singapore.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.